These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21109365)

  • 1. Oral ketamine as a positive control in human abuse potential studies.
    Shram MJ; Sellers EM; Romach MK
    Drug Alcohol Depend; 2011 Apr; 114(2-3):185-93. PubMed ID: 21109365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do formulation differences alter abuse liability of methylphenidate? A placebo-controlled, randomized, double-blind, crossover study in recreational drug users.
    Parasrampuria DA; Schoedel KA; Schuller R; Silber SA; Ciccone PE; Gu J; Sellers EM
    J Clin Psychopharmacol; 2007 Oct; 27(5):459-67. PubMed ID: 17873677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the abuse potential of lorcaserin, a serotonin 2C (5-HT2C) receptor agonist, in recreational polydrug users.
    Shram MJ; Schoedel KA; Bartlett C; Shazer RL; Anderson CM; Sellers EM
    Clin Pharmacol Ther; 2011 May; 89(5):683-92. PubMed ID: 21412231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abuse liability assessment of eslicarbazepine acetate in healthy male and female recreational sedative users: A Phase I randomized controlled trial.
    Levy-Cooperman N; Schoedel KA; Chakraborty B; Blum D; Cheng H
    Epilepsy Behav; 2016 Aug; 61():63-71. PubMed ID: 27315134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of pharmacokinetics and pharmacodynamic effects related to abuse potential of a unique oral osmotic-controlled extended-release methylphenidate formulation in humans.
    Parasrampuria DA; Schoedel KA; Schuller R; Gu J; Ciccone P; Silber SA; Sellers EM
    J Clin Pharmacol; 2007 Dec; 47(12):1476-88. PubMed ID: 17962423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human abuse potential and cognitive effects of taranabant, a cannabinoid 1 receptor inverse agonist: a randomized, double-blind, placebo- and active-controlled, crossover study in recreational polydrug users.
    Schoedel KA; Addy C; Chakraborty B; Rosko K; Dunbar S; Maes A; Chen N; Stoch SA; Wagner J; Chodakewitz J; Sellers EM
    J Clin Psychopharmacol; 2012 Aug; 32(4):492-502. PubMed ID: 22722508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.
    Johnson MW; Suess PE; Griffiths RR
    Arch Gen Psychiatry; 2006 Oct; 63(10):1149-57. PubMed ID: 17015817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the abuse potential of extended release hydromorphone versus immediate release hydromorphone.
    Shram MJ; Sathyan G; Khanna S; Tudor IC; Nath R; Thipphawong J; Sellers EM
    J Clin Psychopharmacol; 2010 Feb; 30(1):25-33. PubMed ID: 20075644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative abuse liability and pharmacological effects of meprobamate, triazolam, and butabarbital.
    Zawertailo LA; Busto UE; Kaplan HL; Greenblatt DJ; Sellers EM
    J Clin Psychopharmacol; 2003 Jun; 23(3):269-80. PubMed ID: 12826989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and chronic effects of ketamine on semantic priming: modeling schizophrenia?
    Stefanovic A; Brandner B; Klaassen E; Cregg R; Nagaratnam M; Bromley LM; Das RK; Rossell SL; Morgan CJ; Curran HV
    J Clin Psychopharmacol; 2009 Apr; 29(2):124-33. PubMed ID: 19512973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users.
    Abanades S; Farré M; Barral D; Torrens M; Closas N; Langohr K; Pastor A; de la Torre R
    J Clin Psychopharmacol; 2007 Dec; 27(6):625-38. PubMed ID: 18004131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human abuse potential of brivaracetam in healthy recreational central nervous system depressant users.
    Schoedel KA; Stockis A; Sellers EM
    Epilepsy Behav; 2018 Jan; 78():194-201. PubMed ID: 29153631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond the K-hole: a 3-year longitudinal investigation of the cognitive and subjective effects of ketamine in recreational users who have substantially reduced their use of the drug.
    Morgan CJ; Monaghan L; Curran HV
    Addiction; 2004 Nov; 99(11):1450-61. PubMed ID: 15500598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abuse liability assessment of atomoxetine in a drug-abusing population.
    Jasinski DR; Faries DE; Moore RJ; Schuh LM; Allen AJ
    Drug Alcohol Depend; 2008 May; 95(1-2):140-6. PubMed ID: 18328639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral and subjective effects of d-amphetamine and modafinil in healthy adults.
    Makris AP; Rush CR; Frederich RC; Taylor AC; Kelly TH
    Exp Clin Psychopharmacol; 2007 Apr; 15(2):123-33. PubMed ID: 17469936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial.
    Schoedel KA; Szeto I; Setnik B; Sellers EM; Levy-Cooperman N; Mills C; Etges T; Sommerville K
    Epilepsy Behav; 2018 Nov; 88():162-171. PubMed ID: 30286443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of a subanaesthetic dose of ketamine on emotional and behavioral state in healthy subjects].
    Micallef J; Tardieu S; Gentile S; Fakra E; Jouve E; Sambuc R; Blin O
    Neurophysiol Clin; 2003 Jun; 33(3):138-47. PubMed ID: 12909392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single dose of prednisone does not induce amphetamine-like subjective effects in healthy subjects.
    Warot D; Danjou P; Payan C; Rocher J; Brialy N; Puech AJ
    Therapie; 1995; 50(4):307-12. PubMed ID: 7482385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing chronic whiplash associated pain with a combination of low-dose opioid (remifentanil) and NMDA-antagonist (ketamine).
    Lemming D; Sörensen J; Graven-Nielsen T; Lauber R; Arendt-Nielsen L; Gerdle B
    Eur J Pain; 2007 Oct; 11(7):719-32. PubMed ID: 17197214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive and subjective acute dose effects of intramuscular ketamine in healthy adults.
    Lofwall MR; Griffiths RR; Mintzer MZ
    Exp Clin Psychopharmacol; 2006 Nov; 14(4):439-49. PubMed ID: 17115871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.